α-Conotoxin LvID, an antagonist of α7 nicotinic acetylcholine receptor, mitigates Alzheimer-associated phenotypes by inhibiting Aβ deposition and reactive astrogliosis.

Documenti analoghi

• α-O-Glycosylation at Tyrosine 10 Promotes the Astrocyte Clearance of Amyloid-β Peptide 1-42.
  di: Huang, Lu, et al.
  Pubblicazione: (2026)
• Variable peptide processing of a Conus (Asprella) neocostatus α-conotoxin generates bioactive toxiforms that are potent against distinct nicotinic acetylcholine receptor subtypes.
  di: Ramones, Cydee Marie V, et al.
  Pubblicazione: (2025)
• Ingrilimine, a novel marine cytotoxic and apoptotic cyclic imine toxin with a high affinity and dual activity on human α7 nicotinic acetylcholine receptor.
  di: Delepierre, Muriel, et al.
  Pubblicazione: (2026)
• Prediction of Specificity of α-Conotoxins to Subtypes of Human Nicotinic Acetylcholine Receptors with Semi-supervised Machine Learning.
  di: Do, Hung Nguyen, et al.
  Pubblicazione: (2025)
• From marine predator to pharmacology: Conotoxin diversity, discovery, and therapeutic potential.
  di: Mao, Kai-Lin, et al.
  Pubblicazione: (2026)